UNH Stock Analysis: Huge Q1 Earnings Beat But A New Downtrend?

UNH stock is facing a massive institutional tug-of-war following UnitedHealth Group's explosive Q1 2026 earnings report and a surprise portfolio liquidation. While the healthcare giant crushed Wall Street estimates with an adjusted EPS of $7.23 and raised its full-year guidance above $18.25, the market was shocked by a regulatory 13F filing revealing that Berkshire Hathaway completely dumped its entire 5-million-share position. In this deep-dive analysis, we break down the critical technical support and resistance levels, the falling medical care ratio (MCR) of 83.9%, and exactly who is buying and selling behind the scenes. We also review the latest analyst ratings from JPMorgan and Wells Fargo to see if UnitedHealth is truly undervalued at a 24% discount or if rising Medicare Advantage costs present a structural value trap.

Queries :
UNH stock, UnitedHealth Group stock, UNH stock analysis, UNH stock news, UNH stock prediction, UNH stock price target, why is UNH stock dropping, Berkshire Hathaway sells UNH, UNH Q1 2026 earnings, UNH technical analysis, is UNH undervalued, UNH dividend yield, managed care stocks, top health insurance stocks 2026.

Chapters:
00:00 - UNH Stock Breaking News & Market Overview
02:15 - Core Financials: Q1 Earnings Double Beat & Raised Guidance
04:40 - The Berkshire Hathaway Exit: Why Greg Abel Sold Everything
07:10 - Technical Analysis: Support, Resistance, RSI, and MACD Levels
09:55 - Order Flow Tracking & Institutional Buy/Sell Levels
12:30 - Valuation Framework: Is UNH Undervalued or Overvalued?
14:50 - Ultimate Short-Term and Long-Term Price Predictions

#UNH #UnitedHealth #StockMarket #ValueInvesting #StocksToBuy #EarningsReport #FinanceNews #TechnicalAnalysis

Видео UNH Stock Analysis: Huge Q1 Earnings Beat But A New Downtrend? канала Stock US Radar